Introduction to the GaBI Journal
Generic medicine pricing: on track in Europe?
Innovator companies should focus on innovations
A review of generic medicine pricing in Europe
Biologicals and biosimilars: a review of the science and its implications
A patient-centred paradigm for the biosimilars market
European payer initiatives to reduce prescribing costs through use of generics
A review of patient perspectives on generics substitution: what are the challenges for optimal drug use
Myths, questions, facts about generic drugs in the EU
Generic and therapeutic orphans
How matrix models can support generic medicine prescribing
Source URL: https://gabi-journal.net/20121-table-of-contents.html
Copyright ©2022 GaBI Journal unless otherwise noted.